# Tirzepatide (Spartina) in Obese Kidney Transplant Recipients

> **NCT07423247** · PHASE4 · RECRUITING · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 30 (estimated)

## Conditions studied

- Tirzepatide

## Interventions

- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT07423247
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-07
- **Final completion:** 2026-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07423247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07423247, "Tirzepatide (Spartina) in Obese Kidney Transplant Recipients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07423247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*